TotalMarketCap

Astrazeneca

AZNNYSE United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$290.110 B

$187.08 -1.02%

Close of 6 Nov 2026

As of 6 Nov 2026, Astrazeneca (AZN) has a market capitalization of $290.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #4Merck & Co.MRK$362.2B
  2. #5NovartisNVS$309.0B
  3. #6AstrazenecaAZN$290.1B
  4. #7Abbott LaboratoriesABT$197.0B
  5. #8Novo Nordisk A SNVO$178.7B

What if Astrazeneca were worth as much as…

Open the what-if tool →

Gold $28.2T

$18,208.81

Per share 97.3× higher

Bitcoin $1.53T

$985.25

Per share 5.27× higher

Apple $5.02T

$3,234.47

Per share 17.3× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Astrazeneca are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.